Elizabeth Hougen Insider Profile
11 Followers
Elizabeth Hougen, Director at Artiva Biotherapeutics, Inc., holds ― shares in Artiva Biotherapeutics, Inc. (Ticker: ARTV), holds 82.66K shares in Ionis Pharmaceuticals (Ticker: IONS). Most recently, Elizabeth Hougen ― shares of Artiva Biotherapeutics, Inc. on ― for an estimated value of ―.
Elizabeth Hougen Artiva Biotherapeutics, Inc. (ARTV)Director
Artiva Biotherapeutics, Inc. (ARTV)
Director
Ranked #94,609 out of 109,349 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-45.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Elizabeth Hougen holds in companies
Most Profitable Insider Trade
The most profitable trade made by Elizabeth Hougen
Elizabeth Hougen's Trading History
Artiva Biotherapeutics, Inc.
―
Director
―
―
Ionis Pharmaceuticals
Mar 18, 2026
EVP, Finance & CFO
Uninformative Buy
8.99M
$3.60M
List of latest transactions for each holding click on a transaction to see Elizabeth Hougen's performance on stock
You May Also Like
Elizabeth Hougen insider profile FAQ
What is the percentage of profitable transactions made by Elizabeth Hougen?
The percentage of profitable transactions made by Elizabeth Hougen is 33%.
What is the average return per transaction made by Elizabeth Hougen?
The average return per transaction made by Elizabeth Hougen is -45.20%.
What stocks does Elizabeth Hougen hold?
Elizabeth Hougen holds: ARTV, IONS stocks.
What was Elizabeth Hougen’s latest transaction?
Elizabeth Hougen latest transaction was an Uninformative Buy of ―.
What was Elizabeth Hougen's most profitable transaction?
Elizabeth Hougen’s most profitable transaction was an Informative Sell of IONS stock on February 2, 2026. The return on the trade was 48.30%.
What is Elizabeth Hougen's role in Artiva Biotherapeutics, Inc.?
Elizabeth Hougen's role in Artiva Biotherapeutics, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.